Related Experiment Video
Updated: May 20, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Tenecteplase for Acute Ischemic Stroke: Improved Handling in Emergency Conditions.
Antonio Siniscalchi1, Luca Gallelli2, Sabrina Anticoli3
1Department of Neurology and Stroke Unit, Annunziata Hospital of Cosenza, Cosenza, Italy.
Current Drug Safety
|May 19, 2026
Summary
Tenecteplase offers a more efficient alternative to alteplase for acute ischemic stroke treatment. Its single-bolus administration and shorter duration improve workflow and enable faster reperfusion, potentially enhancing patient outcomes.
Area of Science:
- Neurology
- Pharmacology
- Emergency Medicine
Background:
- Acute ischemic stroke requires rapid thrombolysis.
- Alteplase is the current standard, but has limitations.
- Tenecteplase is a novel recombinant tissue plasminogen activator.
Purpose of the Study:
- To evaluate tenecteplase as an alternative to alteplase for acute ischemic stroke.
- To compare the efficacy and safety profiles of tenecteplase and alteplase.
- To explore the role of tenecteplase in bridging therapy before thrombectomy.
Main Methods:
- Review of clinical studies and trials comparing tenecteplase and alteplase.
- Analysis of administration protocols, treatment duration, and complication rates.
- Assessment of reperfusion times and transfer efficiency to thrombectomy centers.
Main Results:
- Tenecteplase offers practical advantages, including single bolus administration and shorter treatment time.
- Potential for fewer complications compared to alteplase.
- Facilitates faster reperfusion and transfer to thrombectomy-capable centers.
Conclusions:
- Tenecteplase presents a promising alternative to alteplase for acute ischemic stroke thrombolysis.
- Its administration benefits may improve emergency department workflow and patient outcomes.
- Tenecteplase may enhance bridging therapy efficacy for improved recanalization rates.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...